HCA Healthcare, Inc. (HCA) Stock Forecast & Price Target
HCA Healthcare, Inc. · NYSE
$418.92+29.30 (+7.52%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 20 firms covering HCA Healthcare, Inc, 13 rate it Buy or better, 6 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. Targets span $413.00 to $635.00, a moderate spread. The average target of $502.47 sits 20% above the current $418.92. The rating mix has stayed broadly stable, with Buy-side ratings easing from 14 to 13 over recent months. On the fundamentals, the Street sees consensus EPS building from about $7.00 next quarter toward $32.74 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS20 ratings
Moderate Buy
Strong Buy00%
Buy1365%
Hold630%
Sell15%
Strong Sell00%
Based on 20 analysts giving stock ratings to HCA Healthcare, Inc.
As of Jul, 13 of 20 firms rate HCA a Buy (6 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
HCA EPS & revenue forecast
EPS · NEXT QUARTER
$7.00
Range $6.20 – $7.69 · 16 analysts · +1% YoY
Next period, 16 analysts expect HCA Healthcare, Inc. to earn $7.00 a share (range $6.20 – $7.69), versus $6.96 a year earlier. Full-year consensus is $29.92, growing to $32.74 the year after.
REVENUE · NEXT QUARTER
$19.6B
Range $18.8B – $20.1B · 16 analysts · +2% YoY
Revenue is expected to reach $19.6B (range $18.8B – $20.1B), +2.1% year-over-year. Full-year consensus is $78.5B, rising to $82.0B next year.
Top analysts covering HCA Healthcare, Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on HCA.
#1
DM
David Macdonald
Truist Securities · Rank #67
Buy
No targeton HCA
Overall win rate
51%
+ Follow
#2
Ben Hendrix
RBC Capital · Rank #117
Buy
$435.00+3.8% to target
Overall win rate
44%
+ Follow
#3
Stephen Baxter
Wells Fargo
Hold
$369.00-11.9% to target
Coverage
—
+ Follow
#4
Ryan Langston
TD Cowen
Buy
$431.00+2.9% to target
Coverage
—
+ Follow
#5
AM
Andrew Mok CFA
Barclays
Hold
$387.00-7.6% to target
Coverage
—
+ Follow
HCA stock forecast FAQ
What is HCA's average 12-month price target?+
The 19 analysts with a live target average $502.47 for HCA Healthcare, Inc. over the next 12 months, ranging from a $635.00 high to a $413.00 low.
Is HCA stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 20 analyst ratings, 13 are Buy or Strong Buy, 6 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for HCA?+
The Street-high target is $635.00 (UBS), and the Street-low is $413.00 (Bernstein). The average of all 19 active targets is $502.47.
How many Wall Street analysts cover HCA?+
20 analysts have an active rating on HCA Healthcare, Inc., and 19 firms carry a live 12-month price target.
Who is the most accurate analyst covering HCA?+
Among analysts who currently cover HCA, David Macdonald of Truist Securities has the strongest overall Quantellect track record (Rank #67). Their current call is Buy.
What is HCA Healthcare, Inc.'s projected EPS for next quarter?+
The consensus estimate is $7.00 per share (range $6.20 – $7.69) across 16 analysts. Full-year EPS is projected at $29.92, rising to $32.74 the following year.
How much revenue is HCA Healthcare, Inc. expected to report next quarter?+
Consensus revenue is $19.6B (range $18.8B – $20.1B). Full-year revenue is projected at $78.5B, growing to $82.0B next year.
Have analysts been upgrading or downgrading HCA lately?+
As of Jul, 13 of 20 firms rate HCA a Buy (6 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their HCA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
